Grafted human-induced pluripotent stem-cell–derived neurospheres promote motor functional recovery after spinal cord injury in mice

Once their safety is confirmed, human-induced pluripotent stem cells (hiPSCs), which do not entail ethical concerns, may become a preferred cell source for regenerative medicine. Here, we investigated the therapeutic potential of transplanting hiPSC-derived neurospheres (hiPSC-NSs) into nonobese diabetic (NOD)-severe combined immunodeficient (SCID) mice to treat spinal cord injury (SCI). For this, we used a hiPSC clone (201B7), established by transducing four reprogramming factors (Oct3/4, Sox2, Klf4, and c-Myc) into adult human fibroblasts. Grafted hiPSC-NSs survived, migrated, and differentiated into the three major neural lineages (neurons, astrocytes, and oligodendrocytes) within the injured spinal cord. They showed both cell-autonomous and noncell-autonomous (trophic) effects, including synapse formation between hiPSC-NS–derived neurons and host mouse neurons, expression of neurotrophic factors, angiogenesis, axonal regrowth, and increased amounts of myelin in the injured area. These positive effects resulted in significantly better functional recovery compared with vehicle-treated control animals, and the recovery persisted through the end of the observation period, 112 d post-SCI. No tumor formation was observed in the hiPSC-NS–grafted mice. These findings suggest that hiPSCs give rise to neural stem/progenitor cells that support improved function post-SCI and are a promising cell source for its treatment.

[1]  Suk-Ho Lee,et al.  Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. , 2011, The Journal of clinical investigation.

[2]  Yasuko Matsumura,et al.  A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[3]  Alexander Meissner,et al.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.

[4]  Jae Souk Lee,et al.  Transplantation of GABAergic Neurons from ESCs Attenuates Tactile Hypersensitivity Following Spinal Cord Injury , 2010, Stem cells.

[5]  Stephen E. Strauss.  Geron trial resumes, but standards for stem cell trials remain elusive , 2010, Nature Biotechnology.

[6]  P. Reier,et al.  Neuronal progenitor transplantation and respiratory outcomes following upper cervical spinal cord injury in adult rats , 2010, Experimental Neurology.

[7]  J. Kohyama,et al.  Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury. , 2010, The Journal of clinical investigation.

[8]  Brian J Cummings,et al.  Human Neural Stem Cells Differentiate and Promote Locomotor Recovery in an Early Chronic Spinal coRd Injury NOD-scid Mouse Model , 2010, PloS one.

[9]  V. Edgerton,et al.  Local and Remote Growth Factor Effects after Primate Spinal Cord Injury , 2010, The Journal of Neuroscience.

[10]  Hideyuki Okano,et al.  Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury , 2010, Proceedings of the National Academy of Sciences.

[11]  B. Gwag,et al.  The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury. , 2010, Journal of neurotrauma.

[12]  I. Fischer,et al.  Promoting directional axon growth from neural progenitors grafted into the injured spinal cord , 2009, Journal of neuroscience research.

[13]  Monica Siegenthaler,et al.  Human Embryonic Stem Cell‐Derived Oligodendrocyte Progenitor Cell Transplants Improve Recovery after Cervical Spinal Cord Injury , 2009, Stem cells.

[14]  김동욱,et al.  Transplantation of GABAergic neurons from ESCs attenuates tactile hypersensitivity following spinal cord injury , 2010 .

[15]  H. Okano,et al.  Roles of ES Cell-Derived Gliogenic Neural Stem/Progenitor Cells in Functional Recovery after Spinal Cord Injury , 2009, PloS one.

[16]  M. Hasegawa,et al.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[17]  Hideyuki Okano,et al.  Variation in the safety of induced pluripotent stem cell lines , 2009, Nature Biotechnology.

[18]  Dong Wook Han,et al.  Generation of induced pluripotent stem cells using recombinant proteins. , 2009, Cell stem cell.

[19]  J. E. Lee,et al.  Ex Vivo VEGF Delivery by Neural Stem Cells Enhances Proliferation of Glial Progenitors, Angiogenesis, and Tissue Sparing after Spinal Cord Injury , 2009, PloS one.

[20]  小川 大輔.  Evaluation of human fetal neural stem/progenitor cells as a source for cell replacement therapy for neurological disorders : properties and tumorigenicity after long-term in vitro maintenance , 2009 .

[21]  A. Koizumi,et al.  Spatiotemporal Recapitulation of Central Nervous System Development by Murine Embryonic Stem Cell‐Derived Neural Stem/Progenitor Cells , 2008, Stem Cells.

[22]  Shinya Yamanaka,et al.  Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors , 2008, Science.

[23]  B. Thiers.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[24]  H. Okano,et al.  Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury , 2007, Journal of neuroscience research.

[25]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[26]  V. Koliatsos,et al.  Extensive Neuronal Differentiation of Human Neural Stem Cell Grafts in Adult Rat Spinal Cord , 2007, PLoS medicine.

[27]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[28]  H. Dai,et al.  Degradation of chondroitin sulfate proteoglycans potentiates transplant‐mediated axonal remodeling and functional recovery after spinal cord injury in adult rats , 2006, The Journal of comparative neurology.

[29]  O. Lindvall,et al.  Stem cells for the treatment of neurological disorders , 2006, Nature.

[30]  Li Zhang,et al.  Gene expression profiling reveals the profound upregulation of hypoxia-responsive genes in primary human astrocytes. , 2006, Physiological genomics.

[31]  C. Contag,et al.  In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  M. Murray,et al.  Transplantation of Neuronal and Glial Restricted Precursors into Contused Spinal Cord Improves Bladder and Motor Functions, Decreases Thermal Hypersensitivity, and Modifies Intraspinal Circuitry , 2005, The Journal of Neuroscience.

[33]  Nobuko Uchida,et al.  Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Oswald Steward,et al.  Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore Locomotion after Spinal Cord Injury , 2005, The Journal of Neuroscience.

[35]  S. Strittmatter,et al.  Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury , 2005, Molecular and Cellular Neuroscience.

[36]  H. Okano,et al.  Transplantation of human neural stem cells for spinal cord injury in primates , 2005, Journal of neuroscience research.

[37]  Jonas Frisén,et al.  Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome , 2005, Nature Neuroscience.

[38]  T. Shimazaki,et al.  Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells. , 2004, Developmental biology.

[39]  H. Okano,et al.  Comparison between Fetal Spinal-Cord- and Forebrain-Derived Neural Stem/Progenitor Cells as a Source of Transplantation for Spinal Cord Injury , 2004, Developmental Neuroscience.

[40]  Alexander Sasha Rabchevsky,et al.  Experimental modeling of spinal cord injury: characterization of a force-defined injury device. , 2003, Journal of neurotrauma.

[41]  H. Okano,et al.  Transplantation of in vitro‐expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats , 2002, Journal of neuroscience research.

[42]  T. Matsumiya,et al.  Platelet-activating factor enhances the expression of vascular endothelial growth factor in normal human astrocytes , 2002, Brain Research.

[43]  A. Manira,et al.  Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Tuszynski,et al.  Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury , 2001, The Journal of physiology.

[45]  A. Björklund,et al.  Cell replacement therapies for central nervous system disorders , 2000, Nature Neuroscience.

[46]  F. Gage,et al.  Mammalian neural stem cells. , 2000, Science.

[47]  A. Krassioukov,et al.  Neutralizing Intraspinal Nerve Growth Factor Blocks Autonomic Dysreflexia Caused By Spinal Cord Injury , 1999, The Journal of Neuroscience.

[48]  Marion Murray,et al.  Direct Agonists for Serotonin Receptors Enhance Locomotor Function in Rats that Received Neural Transplants after Neonatal Spinal Transection , 1999, The Journal of Neuroscience.

[49]  B. Stokes,et al.  Brain-Derived Neurotrophic Factor Stimulates Hindlimb Stepping and Sprouting of Cholinergic Fibers after Spinal Cord Injury , 1998, Experimental Neurology.

[50]  L. Weaver,et al.  Sprouting of primary afferent fibers after spinal cord transection in the rat , 1998, Neuroscience.

[51]  S. Wiegand,et al.  BDNF and NT-4/5 Prevent Atrophy of Rat Rubrospinal Neurons after Cervical Axotomy, Stimulate GAP-43 and Tα1-Tubulin mRNA Expression, and Promote Axonal Regeneration , 1997, The Journal of Neuroscience.

[52]  W. Young,et al.  Endogenous Repair after Spinal Cord Contusion Injuries in the Rat , 1997, Experimental Neurology.

[53]  M. Tuszynski.  Gene Therapy for Nervous System Disease a , 1997, Annals of the New York Academy of Sciences.

[54]  N. Bowery,et al.  GABA and its receptors in the spinal cord. , 1996, Trends in pharmacological sciences.

[55]  W. Young,et al.  The Recovery of 5-HT Immunoreactivity in Lumbosacral Spinal Cord and Locomotor Function after Thoracic Hemisection , 1996, Experimental Neurology.

[56]  F. Gage,et al.  Nerve Growth Factor Delivery by Gene Transfer Induces Differential Outgrowth of Sensory, Motor, and Noradrenergic Neurites after Adult Spinal Cord Injury , 1996, Experimental Neurology.

[57]  S. P. Schneider,et al.  Involvement of GABA and glycine in recurrent inhibition of spinal motoneurons. , 1992, Journal of neurophysiology.

[58]  J. Geiger.  Adenosine uptake and [3H]nitrobenzylthioinosine binding in developing rat brain , 1987, Brain Research.

[59]  B. Bregman.  Spinal cord transplants permit the growth of serotonergic axons across the site of neonatal spinal cord transection. , 1987, Brain research.